2018 Sep 4. pii: S0306-4603(18)30834-7. doi: 10.1016/j.addbeh.2018.08.027. [Epub ahead of print]

A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?

1: University of Roehampton, London, United Kingdom; All-Party Parliamentary Group for Prescribed Drug Dependence, United Kingdom. Electronic address: jp.davies@roehampton.ac.uk.
2: University of East London, London, United Kingdom; International Institute for Psychiatric Drug Withdrawal, Sweden.

Abstract

INTRODUCTION:

The U.K.'s current National Institute for Health and Care Excellence and the American Psychiatric Association's depression guidelines state that withdrawal reactions from antidepressants are 'self-limiting' (i.e. typically resolving between 1 and 2weeks). This systematic review assesses that claim.

METHODS:

A systematic literature review was undertaken to ascertain the incidence, severity and duration of antidepressant withdrawal reactions. We identified 24 relevant studies, with diverse methodologies and sample sizes.

RESULTS:

Withdrawal incidence rates from 14 studies ranged from 27% to 86% with a weighted average of 56%. Four large studies of severity produced a weighted average of 46% of those experiencing antidepressant withdrawal effects endorsing the most extreme severity rating on offer. Seven of the ten very diverse studies providing data on duration contradict the UK and USA withdrawal Guidelines in that they found that a significant proportion of people who experience withdrawal do so for more than two weeks, and that it is not uncommon for people to experience withdrawal for several months. The findings of the only four studies calculating mean duration were, for quite heterogeneous populations, 5days, 10days, 43days and 79weeks.

CONCLUSIONS:

We recommend that U.K. and U.S.A. guidelines on antidepressant withdrawal be urgently updated as they are clearly at variance with the evidence on the incidence, severity and duration of antidepressant withdrawal, and are probably leading to the widespread misdiagnosing of withdrawal, the consequent lengthening of antidepressant use, much unnecessary antidepressant prescribing and higher rates of antidepressant prescriptions overall. We also recommend that prescribers fully inform patients about the possibility of withdrawal effects.

PMID:: 30292574
DOI:: 10.1016/j.addbeh.2018.08.027

FULL TEXT: http://prescribeddrug.org/wp-content/uploads/2018/10/Davies-Read.pdf

Post-SSRI Sexual Dysfunction (PSSD)